PharmaEssentia Corporation (LUX:261280558)
17.10
0.00 (0.00%)
At close: May 9, 2025
PharmaEssentia Revenue
PharmaEssentia had revenue of 3.26B TWD in the quarter ending March 31, 2025, with 97.00% growth. This brings the company's revenue in the last twelve months to 11.34B, up 93.12% year-over-year. In the year 2024, PharmaEssentia had annual revenue of 9.73B with 90.67% growth.
Revenue (ttm)
11.34B TWD
Revenue Growth
+93.12%
P/S Ratio
15.41
Revenue / Employee
86.55M TWD
Employees
131
Market Cap
4.86B EUR
Revenue Chart
* This company reports financials in TWD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 9.73B | 4.63B | 90.67% |
Dec 31, 2023 | 5.11B | 2.22B | 77.15% |
Dec 31, 2022 | 2.88B | 2.23B | 339.00% |
Dec 31, 2021 | 656.51M | 99.25M | 17.81% |
Dec 31, 2020 | 557.26M | 251.57M | 82.29% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Reinet Investments S.C.A. | 1.04B |
Luxempart | 50.29M |
CPI FIM | 147.67M |
Socfinasia | 186.43M |
Socfinaf | 591.38M |
Velcan Holdings | 2.95M |
GP Investments | -20.08M |